Novel Injection Dose and Delivery of Varicella-Zoster Virus Vaccine
The immunogenicity of low dose VZV vaccine delivered into the outer layers of skin compared with the standard dose delivered conventionally is investigated.
Herpes Zoster/Varicella Zoster
British Association of Dermatologists Publishes Rapid Update on Use of Biologic Therapies for Psoriasis
The guideline provides current, evidence-based recommendations on the use of biologic therapies in adults, children, and young people for the treatment of psoriasis.
Acyclovir Not Beneficial With HSV Oropharyngeal Reactivation
Preemptive use of acyclovir does not seem to reduce the duration of mechanical ventilation in critically ill patients with herpes simplex virus (HSV) oropharyngeal reactivation.
Review Estimates Costs Associated With Herpes Zoster Among US Adults
Herpes zoster is a substantial societal burden that results in significant direct, indirect, and psychosocial costs, according to the findings of a recently published systematic review.
Herpes Zoster Vaccine Administration: New ACIP Recommendations
The Advisory Committee on Immunization Practices has updated its recommendations on the use of herpes zoster vaccines.
Adjuvant Herpes Zoster Subunit Vaccine More Cost-Effective Than Live Attenuated Vaccine
The new adjuvant herpes zoster subunit vaccine would cost less and offer good value compared with the current live attenuated herpes zoster vaccine.
Psoriasis Treatment With Biologic, Systemic Therapies Has No Effect on Herpes Zoster Risk
There was little difference in risk of herpes zoster among patients who were or weren’t taking biologic or systemic therapies.
Dermatologists Should Be Aware of Herpes Zoster Risk Factors
Women face an especially high risk for developing herpes zoster compared with men.
Herpes Zoster Vaccine Rates Improved With Tracking System
The herpes zoster vaccine rates improved with the electronic notification system.
- Loading...
Loading...
Next post in Infections
Loading... 
Loading...